| Financial Year |
March 31 2023 |
| Monetary Funds |
2,456,594,877.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
92,327.02 |
| Accounts Receivable |
276,254,284.40 |
| Advances to Suppliers |
124,712,288.10 |
| Other Receivables |
23,716,883.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,439,143.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,744,824.51 |
| Other Current Assets |
55,089,076.03 |
| Total Current Assets |
3,096,757,102.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,701,412.01 |
| Long-term Equity Investment |
163,969,793.65 |
| Investment Properties |
40,644,398.77 |
| Fixed Assetes |
435,284,837.70 |
| Under-construction Projects |
543,264,189.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,922,201.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,985,181.57 |
| Other Non-Current Assets |
44,561,215.45 |
| Sub-Total of Non-Current Assets |
1,476,523,229.70 |
| Total Assets |
4,573,280,332.57 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
65,859,257.02 |
| Accounts Payable |
140,417,578.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,499,692.57 |
| Taxes Payable |
11,207,487.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,148,883.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,143,072.04 |
| Other Current Liabilities |
7,096,591.51 |
| Sub-Total of Current Liabilities |
410,834,134.07 |
| Long-term Loans |
385,720,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
397,316,513.61 |
| Total Liabilities |
808,150,647.68 |
| Paid-In Capital(Or Share Stock) |
510,133,604.00 |
| Capital Surplus |
2,602,776,937.73 |
| Surplus Reserve |
44,106,035.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
536,265,524.75 |
| Minority Stockholder's Interest |
61,192,991.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,703,936,693.35 |
| Owner's Equity（Stockholder's Equity） |
3,765,129,684.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,573,280,332.57 |
